Eva Karlsson
Örebro University(SE)
Publications by Year
Research Areas
Pharmaceutical Practices and Patient Outcomes, Pharmaceutical studies and practices, Breast Cancer Treatment Studies, Health Systems, Economic Evaluations, Quality of Life, HER2/EGFR in Cancer Research
Most-Cited Works
- → Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression(2012)532 cited
- → The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm(2011)222 cited
- → HER2 status in a population-derived breast cancer cohort: discordances during tumor progression(2010)118 cited
- → High adherence to the ‘Wise List’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines(2017)108 cited
- → Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer(2016)98 cited
- → Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations(2013)86 cited
- → Medication errors as malpractice-a qualitative content analysis of 585 medication errors by nurses in Sweden(2016)74 cited
- → Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic(2006)51 cited
- → Societal cost of subcutaneous and intravenous trastuzumab for HER2-positive breast cancer – An observational study prospectively recording resource utilization in a Swedish healthcare setting(2016)45 cited
- → Periodontitis from the patient’s perspective, a qualitative study(2009)29 cited